Title 13. Miscellaneous Health Care Programs — Subtitle 12. Maternal Mortality Review Program
Statutes in effect as of October 1, 2026.
Md. Code Ann., Health-Gen. § 13-1201 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 12. Maternal Mortality Review Program
§ 13–1201LinkCopy Citation
(a)
In this subtitle the following words have the meanings indicated.
(b)
“Data use agreement” means an agreement between the Department and a national, State, or local agency or program that establishes the terms and conditions for the confidential submission, collection, storage, analysis, reporting, aggregation, and dissemination of de–identified data obtained from the Maternal Mortality Review Program.
(c)
“Local team” means the multidisciplinary and multiagency maternal mortality review team established for a county.
(d)
“Maternal death” means the death of a woman during pregnancy or within 1 year after the woman ceases to be pregnant.
(e)
“Maternal mortality review committee” means the maternal mortality review committee of MedChi that is a medical review committee, as defined under § 1–401 of the Health Occupations Article.
(f)
“MedChi” means the Maryland State Medical Society.
Md. Code Ann., Health-Gen. § 13-1202 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 12. Maternal Mortality Review Program
§ 13–1202LinkCopy Citation
The General Assembly finds that:
(1)
Maternal deaths are a serious public health concern and have a tremendous family and societal impact;
(2)
Maternal deaths are significantly underestimated and inadequately documented, preventing efforts to identify and reduce or eliminate the causes of death;
(3)
No processes exist in the State for the confidential identification, investigation, or dissemination of findings regarding maternal deaths; and
(4)
There is a need to establish a Maternal Mortality Review Program to review maternal deaths and to develop strategies for the prevention of maternal deaths.
Md. Code Ann., Health-Gen. § 13-1203 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 12. Maternal Mortality Review Program
§ 13–1203LinkCopy Citation
The Secretary shall establish a Maternal Mortality Review Program to review maternal deaths and to develop strategies for the prevention of maternal deaths.
Md. Code Ann., Health-Gen. § 13-1204 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 12. Maternal Mortality Review Program
§ 13–1204LinkCopy Citation
(a)
The Secretary may contract with MedChi to administer the Maternal Mortality Review Program.
(b)
In consultation with the maternal mortality review committee of MedChi, the Secretary shall develop a system to:
(1)
Identify maternal death cases;
(2)
Review medical records and other relevant data;
(3)
Contact family members and other affected or involved persons to collect additional relevant data;
(4)
Consult with relevant experts to evaluate the records and data collected;
(5)
Make determinations regarding the preventability of maternal deaths;
(6)
Develop recommendations for the prevention of maternal deaths; and
(7)
Disseminate findings and recommendations to policy makers, health care providers, health care facilities, and the general public.
(c)
On the approval of the Secretary and with a signed data use agreement, the Department may release de–identified data and findings to the Centers for Disease Control and Prevention, local maternal mortality review teams, and other entities at the discretion of the Secretary.
(d)
In accordance with § 4–221 of this article and notwithstanding § 4–224 of this article, the Secretary shall provide the Program with:
(1)
Information on maternal death cases when the records become available, including a copy of the death certificate; and
(2)
Medical information from the birth or fetal death record for any pregnancy that occurred within 1 year before the death of the woman, excluding Social Security numbers, addresses, and names of the infants.
(e)
On the request of the Secretary, the Program shall be provided access, to the extent allowed by law, to all information and records maintained by a State or local government agency, law enforcement investigative information, medical examiner investigative information, parole and probation information and records, and information and records of a social services agency that provided services to a woman whose death is being reviewed by the Program.
(f)
The Maternal Mortality Review Program, in consultation with the Office of Minority Health and Health Disparities, shall make recommendations to reduce any disparities in the maternal mortality rate including recommendations related to social determinants of health.
Md. Code Ann., Health-Gen. § 13-1205 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 12. Maternal Mortality Review Program
§ 13–1205LinkCopy Citation
(a)
A health care provider or health care facility, as defined under Title 19, Subtitles 3, 3A, and 3B of this article, shall provide the Maternal Mortality Review Program reasonable access to all relevant medical records associated with a case under review by the Maternal Mortality Review Program.
(b)
A health care provider or health care facility, as defined under Title 19, Subtitles 3, 3A, and 3B of this article, shall provide to the local team, on request of the chair, prompt access to all relevant medical records associated with a case under review by the Maternal Mortality Review Program without undue delay.
(c)
The provisions of Title 4, Subtitle 3 of this article do not apply to a disclosure made to the Program or to a local team under this subtitle.
Md. Code Ann., Health-Gen. § 13-1206 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 12. Maternal Mortality Review Program
§ 13–1206LinkCopy Citation
(a)
Notwithstanding the provisions of Title 4, Subtitle 3 of this article, if a patient of a health care provider or a health care facility dies of a maternal death and the health care provider or the health care facility has knowledge of the circumstances of the death, the health care provider or the health care facility shall report the death to the Maternal Mortality Review Program.
(b)
Any health care provider and health care facility report required under this section shall be:
(1)
Confidential;
(2)
Not open to public inspection; and
(3)
Except under a court order sealing the court record, not subject to subpoena or discovery in any criminal or civil proceeding.
(c)
A health care provider or health care facility may not be held liable for civil damages or subject to any criminal or disciplinary action for good faith efforts made to comply with the provisions of this subtitle.
Md. Code Ann., Health-Gen. § 13-1207 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 12. Maternal Mortality Review Program
§ 13–1207LinkCopy Citation
(a)
(1)
Subject to paragraph (2) of this subsection, there may be a multidisciplinary and multiagency maternal mortality review team in each county.
(2)
(i)
Two or more counties may agree to establish a single multicounty local team.
(ii)
A multicounty local team shall execute a memorandum of understanding on membership, staffing, and operation.
(b)
If a local team is established in a county, the local team:
(1)
Shall be convened by the local health officer; and
(2)
May include representatives from other local agencies and local organizations, licensed health care providers with expertise in maternal child health, and other individuals necessary to the work of the local team, recommended by the local team, and designated by the local health officer.
(c)
From among its members, each local team shall elect a chair by majority vote.
Md. Code Ann., Health-Gen. § 13-1208 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 12. Maternal Mortality Review Program
§ 13–1208LinkCopy Citation
(a)
The purpose of a local team is to prevent maternal deaths by:
(1)
Promoting cooperation and coordination among agencies involved in preventing and responding to maternal deaths or in providing services to surviving family members;
(2)
Developing an understanding of the causes and incidence of maternal deaths in the county;
(3)
Developing plans for and recommending changes within the community, local institutions, and agencies the members represent to prevent maternal deaths; and
(4)
Advising the Maternal Mortality Review Program on changes to law, policy, or practice to prevent maternal deaths.
(b)
To achieve its purpose, a local team shall:
(1)
In consultation with the Maternal Mortality Review Program, establish and implement a protocol for the local team;
(2)
Meet at least annually to review the status of maternal fatality cases, recommend actions to improve coordination of services in the community, and recommend actions within local institutions and member agencies to prevent maternal deaths;
(3)
Enter into a data use agreement with the Department for the receipt of information from the Maternal Mortality Review Program necessary to carry out the local team’s purpose and duties; and
(4)
Provide reports to the Maternal Mortality Review Program, including:
(i)
Information on, and local team discussions related to, individual cases;
(ii)
Any racial disparities observed during case review;
(iii)
Steps taken to improve coordination of services and investigations;
(iv)
Steps taken to implement changes recommended by the local team within member agencies; and
(v)
Recommendations on necessary changes to State and local law, policy, and practice to prevent maternal deaths.
Md. Code Ann., Health-Gen. § 13-1209 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 12. Maternal Mortality Review Program
§ 13–1209LinkCopy Citation
On request of the chair of the local team and as necessary to carry out the local team’s purpose and duties, the local team shall be provided:
(1)
Access to all relevant information and records in accordance with the local team’s data use agreement with the Department; and
(2)
Access, to the extent allowed by law, to all information and records maintained by any State or local government agency, law enforcement investigative information, medical examiner investigative information, parole and probation information and records, and information and records of a social services agency that provided services to a woman whose death is being reviewed by the local team.
Md. Code Ann., Health-Gen. § 13-1210 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 12. Maternal Mortality Review Program
§ 13–1210LinkCopy Citation
(a)
A meeting of a local team shall be closed to the public and not subject to Title 3 of the General Provisions Article when a local team is discussing individual cases of maternal deaths.
(b)
Subject to subsection (c) of this section, a meeting of a local team shall be open to the public and subject to Title 3 of the General Provisions Article when the local team is not discussing individual cases of maternal deaths.
(c)
(1)
During a public meeting, information may not be disclosed that identifies:
(i)
A deceased woman; or
(ii)
A family member, guardian, or caretaker of a deceased woman.
(2)
During a public meeting, information may not be disclosed regarding the involvement of any agency with:
(i)
A deceased woman; or
(ii)
A family member, guardian, or caretaker of a deceased woman.
(d)
This section does not prohibit a local team from requesting the attendance at a team meeting of an individual who has information relevant to the team’s performance of its purpose and duties.
(e)
A violation of this section is a misdemeanor and is punishable by a fine not exceeding $500 or imprisonment not exceeding 90 days or both.
Md. Code Ann., Health-Gen. § 13-1211 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 12. Maternal Mortality Review Program
§ 13–1211LinkCopy Citation
(a)
Except as otherwise provided in this section, the proceedings, records, and files of a local team are confidential and privileged, and are not discoverable or admissible as evidence in any civil or criminal proceeding.
(b)
Statistical compilations of data that do not contain any information that would cause the identification of any person to be ascertained are public records.
(c)
Reports of a local team that do not contain any information that would cause the identification of any person to be ascertained are public information.
(d)
A member of a team and an individual attending a team meeting may not disclose what transpired at a meeting that is not public under § 13–1210 of this subtitle or any information the disclosure of which is prohibited by this section.
(e)
(1)
Subject to paragraph (2) of this subsection, a member of a team, an individual attending a team meeting, and an individual who presents information to a team may not be questioned in any civil or criminal proceeding regarding information presented in or opinions formed as a result of a meeting.
(2)
Paragraph (1) of this subsection does not prohibit an individual from testifying to information obtained independently of the team or that is public information.
Md. Code Ann., Health-Gen. § 13-1212 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 12. Maternal Mortality Review Program
§ 13–1212LinkCopy Citation
(a)
On or before December 1 of each year, the Secretary shall submit a report on findings, recommendations, and Program actions to the Governor and, subject to § 2–1257 of the State Government Article, to the General Assembly.
(b)
The Secretary shall include in the report required under subsection (a) of this section:
(1)
A summary of any stakeholder meetings held under § 13–1213 of this subtitle during the immediately preceding 12–month period that includes:
(i)
Stakeholder responses to existing recommendations; and
(ii)
Recommendations from stakeholders that address factors contributing to maternal mortality; and
(2)
A section on racial disparities that includes:
(i)
A comparison of the maternal mortality rates of non–Hispanic black and non–Hispanic white women;
(ii)
Data on changes in the maternal mortality rate by race and ethnicity;
(iii)
The number of live births by race;
(iv)
The percentage of women who gave birth by race;
(v)
The percentage of maternal deaths by race and ethnicity;
(vi)
The maternal mortality rate by race;
(vii)
A comparison of the leading causes of maternal death by race; and
(viii)
Any other information that the Secretary determines necessary to carry out the purposes of this subtitle.
Md. Code Ann., Health-Gen. § 13-1213 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 12. Maternal Mortality Review Program
§ 13–1213LinkCopy Citation
(a)
(1)
Subject to paragraph (2) of this subsection, at least twice a year, the Secretary shall convene a meeting of stakeholders, including:
(i)
Representatives of:
(1)
The Maryland Office of Minority Health and Health Disparities;
(2)
The Maryland Patient Safety Center;
(3)
The Maryland Healthy Start Program;
(4)
Women’s health advocacy organizations;
(5)
Community organizations engaged in maternal health and family support issues;
(6)
Local health departments; and
(7)
Health care providers that provide maternal health services; and
(ii)
(1)
Families of women who have experienced a near maternal death, a high–risk pregnancy, other challenges during pregnancy, or a maternal death; or
(2)
Women who have experienced a near maternal death, a high–risk pregnancy, or other challenges during pregnancy.
(2)
To the extent practicable, the stakeholders convened in accordance with paragraph (1) of this subsection shall reflect the racial and ethnic diversity of women most impacted by maternal deaths in the State.
(b)
Of the two meetings required under subsection (a) of this section:
(1)
One meeting shall be held within 90 days after submission of the report required under § 13–1212 of this subtitle to:
(i)
Review the findings and recommendations in the report;
(ii)
Examine issues resulting in disparities in maternal deaths;
(iii)
Review the status of implementation of previous recommendations; and
(iv)
Identify new recommendations with a focus on initiatives to address issues resulting in disparities in maternal deaths; and
(2)
One meeting shall be held within 6 months after the meeting held under item (1) of this subsection to review the status of implementation of previous recommendations and consider any new information that may be relevant for the identification of additional recommendations.